Product Program year 2025 Source: CMS Open Payments

Enflonsia

Drug Infectious Disease

NDC 0006-5073-01

Open in the dashboard

General payments

$488,971

13,452 payments

Research payments

$709,200

105 payments

Through program year 2025, $488,971 in general payments and $709,200 in research payments were reported against Enflonsia (Infectious Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $488,971 13,452
2025 Research $709,200 105

Breakdown

Who paid General payments · program year 2025
  1. Merck Sharp & Dohme Corporation $488,971 13,452 payments
Top recipients General payments · program year 2025
  1. Octavio Ramilo Pediatric Infectious Diseases · Memphis, TN $38,408 8% · 28 payments
  2. Christopher Belcher Pediatric Infectious Diseases · Carmel, IN $34,142 7% · 27 payments
  3. Laura Scalfano Pediatrics · Plano, TX $24,457 5% · 32 payments
  4. Flor De Maria Munoz Pediatric Infectious Diseases · Houston, TX $22,920 5% · 29 payments
  5. Marcus Degraw Pediatrics · Detroit, MI $17,110 3% · 20 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatrics $201,590 42% · 4,810 practitioners
  2. Pediatric Infectious Diseases Pediatrics $124,527 26% · 24 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $32,487 7% · 1,398 practitioners
  4. Family Medicine $31,331 7% · 1,226 practitioners
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $23,767 5% · 972 practitioners

The top 5 of 113 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $87,787 18% · 922 recipients
  2. Tennessee $51,742 11% · 365 recipients
  3. California $43,932 9% · 1,319 recipients
  4. Indiana $38,687 8% · 213 recipients
  5. Pennsylvania $31,501 6% · 364 recipients

The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

13,452 general · 105 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record